US equities
|
MU
$1,065.89
▼-2.03%
NVDA
$236.03
▼-0.61%
PLTR
$201.71
▲+3.91%
SNDK
$1,646.69
▼-2.70%
META
$720.51
▼-0.11%
AMD
$636.85
▼-1.40%
TSLA
$372.33
▼-1.45%
INTC
$109.91
▼-2.84%
MU
$1,065.89
▼-2.03%
NVDA
$236.03
▼-0.61%
PLTR
$201.71
▲+3.91%
SNDK
$1,646.69
▼-2.70%
META
$720.51
▼-0.11%
AMD
$636.85
▼-1.40%
TSLA
$372.33
▼-1.45%
INTC
$109.91
▼-2.84%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
iShares ESG Aware MSCI USA Small-Cap ETF
(NY:
ESML
)
52.11
-0.21 (-0.40%)
Delayed Quote
Updated: 10:13 AM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iShares ESG Aware MSCI USA Small-Cap ETF
MLTX Stock Gains As Retail Eyes Buyout From Big Pharma, Upcoming Investor Day Event
↗
February 17, 2026
Some Stocktwits users voiced optimism for the inflammation-drug maker getting acquired by pharma giant Merck.
Via
Stocktwits
Topics
Intellectual Property
Stanich Group Sells $5 Million of iShares ESG Aware USD Corporate Bond ETF
↗
February 02, 2026
iShares ESG Aware USD Corporate Bond ETF offers exposure to investment-grade bonds with an ESG focus and a disciplined, passive strategy.
Via
The Motley Fool
Topics
Bonds
Derivatives
ETFs
MLTX Stock Extends Rally As FDA Feedback Spurs Bullish Brokerage Action – Retail Speculates On Potential M&A Conversations
↗
January 09, 2026
Via
Stocktwits
Why Did MLTX Stock Jump 45% In Pre-Market Today?
↗
January 08, 2026
The company said it received positive regulatory feedback from the U.S. FDA following a Type B meeting regarding a drug used to treat hidradenitis suppurativa, a chronic inflammatory skin disorder.
Via
Stocktwits